United States Genome Editing Market Trends, Size, Share | Regional Research & Forecast 2025

"Genome Editing Market reached US$ 9.50 Billion in 2024 and is expected to reach US$ 37.22 Billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/genome-editing-market?sp

United States: Recent Industry Developments

✅ In August 2025, Intellia Therapeutics announced the successful preclinical testing of an in vivo CRISPR therapy for treating hereditary transthyretin amyloidosis. The therapy aims to permanently reduce disease-causing protein levels in patients.

✅ In July 2025, Editas Medicine advanced its CRISPR-based treatment for Leber congenital amaurosis (a rare eye disorder) to Phase 2 clinical trials. This development represents a significant step toward restoring vision in affected individuals.

✅ In June 2025, Beam Therapeutics reported the development of a new base editing platform capable of precise single-nucleotide changes in hematopoietic stem cells. The technology is aimed at treating blood disorders such as sickle cell disease and beta-thalassemia.

Japan: Recent Industry Developments

✅ In August 2025, RIKEN researchers developed a novel genome editing technique for plants that improves crop resilience to heat and drought. This advancement supports sustainable agriculture and food security initiatives.

✅ In July 2025, Osaka University launched a collaborative program with private biotech firms to apply CRISPR technology in regenerative medicine. The program focuses on repairing damaged tissues and organs using genome-edited stem cells.

✅ In June 2025, Kyoto University reported advancements in CRISPR-Cas12a research for viral disease resistance. The approach enables precise and efficient editing of viral DNA in cell cultures, offering potential applications in both medicine and agriculture.

Genome Editing Market: Drivers

The genome editing market is expanding rapidly as biotechnology and pharmaceutical industries increasingly focus on precise, targeted modifications of genetic material to develop novel therapies, improve crop traits, and advance research applications. Genome editing technologies, including CRISPR-Cas systems, TALENs, and zinc finger nucleases, enable researchers to modify DNA sequences with high accuracy, offering opportunities for treating genetic disorders, enhancing disease resistance, and accelerating drug discovery. Rising demand for personalized medicine, regenerative therapies, and agricultural innovation is driving adoption, as genome editing allows tailored interventions for specific genetic profiles and traits. Technological advancements in delivery systems, off-target reduction, and high-throughput screening are enhancing the efficiency, safety, and scalability of genome editing applications. Additionally, integration with bioinformatics and AI-based design tools is facilitating more precise target identification and improved experimental outcomes.

Increasing prevalence of genetic diseases, chronic disorders, and the need for sustainable agriculture are fueling research and investment in genome editing technologies. Pharmaceutical and biotech companies are leveraging genome editing for the development of next-generation therapeutics, including gene therapies, immunotherapies, and cell-based treatments. In agriculture, genome editing is used to improve crop yield, nutritional content, and environmental resilience, supporting global food security. Regulatory frameworks, ethical considerations, and public awareness are shaping responsible deployment and adoption of these technologies. Overall, genome editing is revolutionizing healthcare, agriculture, and life sciences by enabling precise, efficient, and customizable genetic modifications that address complex biological challenges.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/genome-editing-market?sp

Genome Editing Market: Major Players

Thermo Fisher Scientific Inc, Merck KGaA (Sigma-Aldrich), CRISPR Therapeutics AG, Editas Medicine, Inc., Cellectis S.A., Precision BioSciences, Inc., GenScript Biotech Corporation, Lonza Group Ltd., New England Biolabs, Inc., Integrated DNA Technologies, Inc. (IDT) and among others.

Segment Covered in the Genome Editing Market:

➥ By Technology: CRISPR/Cas9, TALENs (Transcription Activator-Like Effector Nucleases), Zinc Finger Nucleases (ZFNs), Meganucleases, Antisense Technologies, Others
➥ By Delivery Method: Ex-vivo, In-vivo
➥ By Application: Genetic Engineering, Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Drug Discovery & Development, Gene-Modified Cell Therapy, Diagnostics, Others
➥ By End User: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations (CROs)

Research Process:

Both primary and secondary data sources have been used in the Genome Editing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Genome Editing Market Research Industry:

➠ Who leads the Genome Editing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Genome Editing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Genome Editing market growth?
➠ What are the dominant sales and distribution strategies in the Genome Editing industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=genome-editing-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.